Oral Vasodilator Protocol Among Advanced Decompensated Heart Failure Patients Managed With Intravenous Vasodilator Therapy

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2018.07.125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prostacyclin and Oral Vasodilator Therapy in Sarcoidosis-Associated Pulmonary Hypertension

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2015English

Nesiritide Enhances Urine Output in Decompensated Advanced Heart Failure Patients

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Side Effects of Vasodilator Therapy.

Hypertension
Internal Medicine
1988English

Vasodilator Therapy in Acute Hemorrhagic Shock

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1965English

Safety of Initiation of Sacubitril/Valsartan in ICU Patients With Advanced Decompensated Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Prognosis and Risk Stratification in Patients With Decompensated Heart Failure Receiving Inotropic Therapy

Open Heart
Cardiovascular MedicineCardiology
2018English

Determinants of Drug Response in Severe Chronic Heart Failure. 1. Activation of Vasoconstrictor Forces During Vasodilator Therapy

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

Can Pulmonary Vasodilator Therapy Expand the Operative Indications for Congenital Heart Disease?

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

Endothelial Cell Activation in Patients With Decompensated Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy